Difficulty: Medium
Average Score: 75%
Testbank
What is a side effect of beta-adrenergic blockers?
Correct answer
C
Rationale
Bradycardia is a common side effect of beta-adrenergic blockers.
Beta-adrenergic blockers, such as atenolol and metoprolol, work by blocking the effects of adrenaline on beta receptors, leading to a decrease in heart rate. This mechanism can result in bradycardia, which is characterized by an abnormally slow heart rate, and is a well-documented adverse effect of these medications.
A: Sedation - While beta-adrenergic blockers can cause fatigue, they do not typically induce sedation, which is more commonly associated with other classes of medications, such as benzodiazepines or antihistamines.
B: Hyperglycemia - Beta-adrenergic blockers can potentially mask hypoglycemia symptoms but are not directly associated with causing hyperglycemia; this effect is more relevant to certain other medications, like corticosteroids.
D: Addiction - Beta-adrenergic blockers do not lead to physical dependence or addiction; this term is more applicable to substances that produce psychological cravings or physical withdrawal symptoms, such as opioids or stimulants.
Beta-adrenergic blockers, such as atenolol and metoprolol, work by blocking the effects of adrenaline on beta receptors, leading to a decrease in heart rate. This mechanism can result in bradycardia, which is characterized by an abnormally slow heart rate, and is a well-documented adverse effect of these medications.
A: Sedation - While beta-adrenergic blockers can cause fatigue, they do not typically induce sedation, which is more commonly associated with other classes of medications, such as benzodiazepines or antihistamines.
B: Hyperglycemia - Beta-adrenergic blockers can potentially mask hypoglycemia symptoms but are not directly associated with causing hyperglycemia; this effect is more relevant to certain other medications, like corticosteroids.
D: Addiction - Beta-adrenergic blockers do not lead to physical dependence or addiction; this term is more applicable to substances that produce psychological cravings or physical withdrawal symptoms, such as opioids or stimulants.